Download PDF
Journal of Pediatric Epilepsy 2018; 07(04): 152-153
DOI: 10.1055/s-0038-1666814
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Adolescent's Hair Loss due to Levetiracetam

Rola S. Hamd
1   Department of Pediatrics and Neuropediatrics Service, Rafic Hariri University Hospital, Beirut, Lebanon
,
Dana A. Hasbini
1   Department of Pediatrics and Neuropediatrics Service, Rafic Hariri University Hospital, Beirut, Lebanon
› Author Affiliations
Further Information

Publication History

06 March 2018

24 May 2018

Publication Date:
03 July 2018 (online)

    Permissions and Reprints

Abstract

Hair loss is a known complication observed with the intake of many medications including a few antiepileptic drugs. We report, in this article, a 13-year-old girl with epilepsy who developed hair loss, which was noted within 2 months of starting levetiracetam. To our knowledge, this is the first case report of hair loss induced by levetiracetam in this age group.

Keywords

alopecia - antiepileptic drugs - epilepsy - levetiracetam - side effect

Disclosures

None.


 

  • References

  • 1 Grünewald R. Levetiracetam in the treatment of idiopathic generalized epilepsies. Epilepsia 2005; 46 (Suppl. 09) 154-160
    CrossrefPubMedGoogle Scholar
  • 2 Zou X, Hong Z, Zhou D. Hair loss with levetiracetam in five patients with epilepsy. Seizure 2014; 23 (02) 158-160
    CrossrefPubMedGoogle Scholar
  • 3 Mercke Y, Sheng H, Khan T, Lippmann S. Hair loss in psychopharmacology. Ann Clin Psychiatry 2000; 12 (01) 35-42
    CrossrefPubMedGoogle Scholar
  • 4 Chen B, Choi H, Hirsch LJ. , et al. Cosmetic side effects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav 2015; 42: 129-137
    CrossrefPubMedGoogle Scholar
  • 5 Tengstrand M, Star K, van Puijenbroek EP, Hill R. Alopecia in association with lamotrigine use: an analysis of individual case safety reports in a global database. Drug Saf 2010; 33 (08) 653-658
    CrossrefPubMedGoogle Scholar
  • 6 Suzuki T, Koizumi J, Moroji T. , et al. Effects of long-term anticonvulsant therapy on copper, zinc, and magnesium in hair and serum of epileptics. Biol Psychiatry 1992; 31 (06) 571-581
    CrossrefPubMedGoogle Scholar
  • 7 Yilmaz Y, Tasdemir HA, Paksu MS. The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity. Eur J Paediatr Neurol 2009; 13 (05) 439-443
    CrossrefPubMedGoogle Scholar
  • 8 Castro-Gago M, Pérez-Gay L, Gómez-Lado C, Castiñeiras-Ramos DE, Otero-Martínez S, Rodríguez-Segade S. The influence of valproic acid and carbamazepine treatment on serum biotin and zinc levels and on biotinidase activity. J Child Neurol 2011; 26 (12) 1522-1524
    CrossrefPubMedGoogle Scholar
  • 9 Calabrò RS, Bramanti P, Spina E, Italiano D. Can zinc depletion play a role in LEV-induced hair loss? Considerations from a case study. Epilepsy Behav 2013; 29 (01) 254-255
    CrossrefPubMedGoogle Scholar